Form 8-K - Current report:
SEC Accession No. 0001193125-23-148115
Filing Date
2023-05-18
Accepted
2023-05-18 16:04:08
Documents
14
Period of Report
2023-05-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d491233d8k.htm   iXBRL 8-K 49808
2 EX-10.1 d491233dex101.htm EX-10.1 34601
  Complete submission text file 0001193125-23-148115.txt   261233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xoma-20230517.xsd EX-101.SCH 3869
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20230517_def.xml EX-101.DEF 14110
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20230517_lab.xml EX-101.LAB 23494
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20230517_pre.xml EX-101.PRE 15143
8 EXTRACTED XBRL INSTANCE DOCUMENT d491233d8k_htm.xml XML 6659
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 23936029
SIC: 2834 Pharmaceutical Preparations